Denis Guttridge to Administration, Oral
This is a "connection" page, showing publications Denis Guttridge has written about Administration, Oral.
Connection Strength
0.052
-
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. J Natl Cancer Inst. 2015 Dec; 107(12):djv274.
Score: 0.030
-
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011; 63(5):749-62.
Score: 0.022